Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05292794 · ClinicalTrials.gov registry record · NA
Use of CereGate Therapy for Freezing of Gait in PD
A NA study of Parkinson Disease and Deep Brain Stimulation, sponsored by CereGate.
- Recruiting
- Registry status
- NA
- Development phase
- 41
- Enrollment target
- 7
- Study locations
NCT05292794 is a NA study of Parkinson Disease and Deep Brain Stimulation that is actively recruiting participants, run by CereGate. The registered enrollment target is 41 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 7 study locations across 7 states.
The verdict
NCT05292794, a NA study of Parkinson Disease and Deep Brain Stimulation, is actively recruiting participants, sponsored by CereGate.
- RECRUITING
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
- 7
- Study locations
Study Summary
A Multi-Center, Controlled Study to Evaluate Use of CereGate Therapy to Reduce Freezing of Gait in Participants Diagnosed with Parkinson's Disease.
Conditions Studied
Interventions
- DEVICE CereGate Software; BSN cDBS Programmer; BSN Burst Programmer
Study Locations (7)
California
- Kaiser Permanente, KPNC Comprehensive Movement Disorders Program - Redwood City
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
Florida
- University of Miami - Miami
Illinois
- Northwestern University - Chicago
North Carolina
- Wake Forest University - Winston-Salem
Tennessee
- Vanderbilt University Medical Center - Nashville
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2022-04-18 |
| Est. Completion | 2027-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05292794
The ClinicalTrials.gov registry entry for NCT05292794 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The listed sponsor is CereGate, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which CereGate Software; BSN cDBS Programmer; BSN Burst Programmer is the first listed.
NCT05292794 reports 7 study locations spanning 7 distinct geographic areas - top geographies include California, Colorado, Florida.
Frequently Asked Questions
What is clinical trial NCT05292794 about?
NCT05292794 is a clinical study titled "Use of CereGate Therapy for Freezing of Gait in PD". A Multi-Center, Controlled Study to Evaluate Use of CereGate Therapy to Reduce Freezing of Gait in Participants Diagnosed with Parkinson's Disease.
What is the current status of trial NCT05292794?
This trial is currently recruiting. It is a NA study. The enrollment target is 41 participants. The study started on 2022-04-18. Estimated completion is 2027-07.
What conditions does trial NCT05292794 study?
This clinical trial studies the following conditions: Parkinson Disease, Deep Brain Stimulation, Freezing of Gait.
What interventions are being tested in trial NCT05292794?
The interventions under investigation include: CereGate Software; BSN cDBS Programmer; BSN Burst Programmer (DEVICE).
Who is sponsoring clinical trial NCT05292794?
This trial is sponsored by CereGate, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05292794 being conducted?
This trial has 7 study locations across California, Colorado, Florida, Illinois, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Neurophysiology of Reward Signaling in Parkinson's Disease
RECRUITING · NA
-
Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease
RECRUITING · NA
-
Rock Steady Boxing: A Community Based In Person Class
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.